
Sign up to save your podcasts
Or


Tom is joined by Sam Chang, Sia Daneshmand, and Petros Grivas to discuss new therapies in non-muscle invasive bladder cancer, including those for BCG-refractory NMIBC and the cretostimogene + pembrolizumab combo for BCG-unresponsive NMIBC.
By The Uromigos4.9
5757 ratings
Tom is joined by Sam Chang, Sia Daneshmand, and Petros Grivas to discuss new therapies in non-muscle invasive bladder cancer, including those for BCG-refractory NMIBC and the cretostimogene + pembrolizumab combo for BCG-unresponsive NMIBC.

21,954 Listeners

32,246 Listeners

30,609 Listeners

504 Listeners

1,309 Listeners

14 Listeners

59 Listeners

8,876 Listeners

23 Listeners

2 Listeners

59 Listeners

2,030 Listeners

2,131 Listeners

195 Listeners

45 Listeners